The role of pharmacoeconomic information from the pharmaceutical industry perspective

E. P. Armstrong, J. Abarca, A. J. Grizzle

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The purpose of this study was to determine the factors that pharmaceutical industry representatives believe are important in the drug benefit decisions of MCOs. Respondents indicated that a drug's clinical features and acquisition cost were the most important factors in making drug-coverage decisions. Ninety percent of respondents indicated that they provide some type of pharmacoeconomic data on either some or almost every visit with their customers. Twenty (95%) of 21 respondents thought that current pharmacoeconomic information was helpful to MCOs in making drug benefit decisions. However, 80% thought important barriers existed to using health outcome and pharmacoeconomic data.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalDrug Benefit Trends
Issue number3
StatePublished - 2001


  • MCOs
  • Pharmaceutical industry
  • Pharmacoeconomics

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)


Dive into the research topics of 'The role of pharmacoeconomic information from the pharmaceutical industry perspective'. Together they form a unique fingerprint.

Cite this